<strong>The controlled release profile of risedronate emulgel to inhibit relapse movement in orthodontic treatment</strong>
Introduction: Relapse is one of the undesirable effects of orthodontic treatment. Prevention of relapse has been carried out with the use of retainer devices. Several studies also have been carried out to prevent relapse with pharmacological agents such as bisphosphonates. One of the strongest bisph...
Main Authors: | Tita Ratya Utari, Muhammad Fariez Kurniawan, Shylvia Muchsin Andewa |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Padjadjaran
2022-04-01
|
Series: | Padjadjaran Journal of Dentistry |
Subjects: | |
Online Access: | http://jurnal.unpad.ac.id/pjd/article/view/32628 |
Similar Items
-
An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate
by: Diane Kleinermans, et al.
Published: (2022-06-01) -
THE EFFECT OF BISPHOSPHONATE RISEDRONATE HYDROGEL ON ALKALINE PHOSPHATASE AND OSTEOCLASTS DURING RELAPSE MOVEMENT
by: Tita Ratya Utari, et al.
Published: (2022-06-01) -
Calcium and Strontium Coordination Polymers as Controlled Delivery Systems of the Anti-Osteoporosis Drug Risedronate and the Augmenting Effect of Solubilizers
by: Maria Vassaki, et al.
Published: (2021-12-01) -
Early bilateral simultaneous atypical femur fracture after 18 months of Risedronate therapy: Case report and literature review
by: Yuri Piccolo, et al.
Published: (2023-12-01) -
First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01)